Global Biodegradable Drug Eluting Stents Market is Expected to Reach US$ 4,876.4 Mn by 2025, Surge in R&D for the Development of Newer Products
Analyst Speak:

“The Global Biodegradable Drug Eluting Stents Market is expected to reach US$ 4,876.4 Mn over the forecast by 2025 owing to grow in R&D for the development of newer products”

The global biodegradable drug eluting stents market is expected to reach US$ 4,876.4 Mn by 2025. In medical terms stent is any device which is inserted into a blood vessel or other internal duct in order to expand the vessel to prevent or alleviate a blockage. A biodegradable stent is made from a material which will dissolve or absorb in the body. The biodegradable drug eluting stent market is driven the increasing prevalence of cardiovascular diseases and more demand of minimally invasive procedure. Moreover, raising geriatric population and favorable reimbursement scenario are also contributing the growth of global biodegradable drug eluting stents market. On the flip side availability of alternative therapies, stringent regulatory approvals and lack of skilled professionals are hampering the growth of global biodegradable drug eluting stent market.

Global biodegradable drug eluting stents market is segmented on the basis of biodegradable polymer type, disease type, end user, and region.

Request Sample Report:
https://www.precisionbusinessinsights.com/request-sample/?product_id=15543

Coronary Artery Diseases Dominate the Global Biodegradable Drug Eluting Stents Market

Based on the disease type, global biodegradable drug eluting stents market is segmented into coronary artery diseases, peripheral artery disease, biliary disease, ureteral disease, pancreatic disease, and others. Coronary artery disease tends to dominate the global biodegradable drug eluting stents market. Coronary artery disease prevalence is increasing due to unhealthy food habits, rise in consumption of alcohol, and increase in the obese people around the world. For instance, according to Centre for Disease Control and Prevention, coronary artery disease is the most common type of heart disease and killing approximately 370,000 people in United States per year. Moreover, launch of newer products into market also boost the biodegradable drug eluting stents market over the forecast timeframe.

North America Leads the Global Biodegradable Drug Eluting Stents Market

PBI’s global biodegradable drug eluting stents market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America biodegradable drug eluting stents market accounted for larger revenue share through 2014-2018 and expected to dominate over 2019-2025 owing to their advancement in research and development sector, favorable government initiatives, growing need for the minimally invasive procedures and rise in prevalence of cardiovascular diseases. However, Europe and Asia Pacific biodegradable drug eluting Stents market is expected to grow at a good rate over the years due to their growing geriatric population, unhealthy dietary habits, increased research activity, improved healthcare infrastructure, raising cardiovascular diseases and emerging economies will surge the growth of biodegradable drug eluting stents market.

Launch of newer products, and strategic alliances are the key strategies adopted by market players

Global biodegradable drug eluting stents market further reveals that the key players increasingly adopting strategies such as launch of newer products, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. In October 2015, Boston Scientific received FDA approval for Synergy, a bioabsorbable polymer drug-eluting stent system used in the treatment of coronary artery disease

Key player’s profiles in the report are Kyoto Medical Planning Co., Ltd. (Japan), Abbott (US), REVA Medical, Inc. (US), Boston Scientific (US), Terumo (Europe), Sahajanand Medical Technologies (SMT) (California) and Elixir Medical Corporation (US).

Precision Business Insights (PBI) in its report titled “Global Biodegradable Drug Eluting Stents Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Detailed Segmentation

By Biodegradable Polymer Type
• Lactic Acid
• Glycolic Acid
• Others

By Disease Type
• Coronary Artery Diseases
• Peripheral Artery Disease
• Biliary Disease
• Ureteral Disease
• Pancreatic Disease
• Others

By End User
• Hospitals & Clinics
• Cardiac Centres
• Ambulatory Surgical Centers

Geography

o North America
• US
• Canada
o Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
o Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific
o Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
o Middle East and Africa (MEA)
• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

For More Information:
https://www.precisionbusinessinsights.com/market-reports/global-biodegradable-drug-eluting-stents-market/

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com